The post is a summary of how things look today and under related reading I have included some past posts that may offer a few more details on how the shift it taking place today. Things are also happening and humming as well in China and you can search and find some recent relative posts here as...
Posted to
The Medical Quack .... by Barbara Duck
on 11-20-2008
Filed under: Pharma/FDA News, My Commentaries, healthcare, Pharma, clinical trials, R and D, India, Economics, Mayo Clinic, Outsourcing, Employment, China pharma
This also means some folks will be losing jobs as well. The unit has been in place since 1991 and has provided information on over 1,000 trials. This is just one more sign of how the face of the pharmaceutical business is changing. It is about one fifth the cost to run trials in countries...
Posted to
The Medical Quack .... by Barbara Duck
on 11-10-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, clinical trials, India, Economics, Mayo Clinic, Outsourcing, China pharma
Great effort on the members of Congress to “ask”, but the end result is what counts. R and D with major pharmaceutical companies is presently in the business of moving overseas to India and China, as well as some clinical trials, so the impact of the request from the members of Congress may or...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, clinical trials, Pfizer, China, R and D, India, Outsourcing
Other Pharma businesses have done or will be doing the same, much of R and D is moving other areas where the cost is 1/5 of that here in the US, so 5 times the number of projects ongoing for the same amount of money, which also means in the same terms there can be 4 failures of drugs in the same cost...
Not just India, but other countries as well. I have posted many articles on the blog referencing outsourcing over the last year or so and all of Big Pharma has interests in foreign countries including the strong possibility of phase 1 clinical trials. The one comment I have to make here...